A mixed-methods study of the technical feasibility and patient acceptability of a real-time adherence monitor in breast cancer survivors taking adjuvant endocrine therapy
Journal Article
Overview
publication date
- October 1, 2022
has subject area
- Antineoplastic Agents, Hormonal
- Attitude - Medication Adherence
- Breast Diseases - Breast Neoplasms
- Cancer Survivors
- Combined Modality Therapy - Chemotherapy, Adjuvant
- Drug Therapy - Chemotherapy, Adjuvant
- Environment and Public Health - Feasibility Studies
- Female
- Health Behavior - Medication Adherence
- Health Care Evaluation Mechanisms - Feasibility Studies
- Health Care Quality, Access, and Evaluation - Medication Adherence
- Humans
- Investigative Techniques - Feasibility Studies
- Investigative Techniques - Feasibility Studies
- Neoplasms by Site - Breast Neoplasms
- Survivors
has restriction
- green
Date in CU Experts
- August 27, 2022 9:57 AM
Full Author List
- Bright EE; Genung SR; Stanton AL; Arch JJ
author count
- 4
citation count
- 1
published in
Other Profiles
International Standard Serial Number (ISSN)
- 0167-6806
Electronic International Standard Serial Number (EISSN)
- 1573-7217
Digital Object Identifier (DOI)
Additional Document Info
start page
- 393
end page
- 399
volume
- 195
issue
- 3